Ignite Creation Date:
2024-05-06 @ 10:21 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03239080
Status:
COMPLETED
Last Update Posted:
2020-11-24
First Post:
2017-08-01
Brief Title:
Effect of Denosumab in Erosion Healing in RA
Sponsor:
Chinese University of Hong Kong
Organization:
Chinese University of Hong Kong
Study Overview
Official Title:
Effect of RANKL Inhibition on Healing of Bone Erosion in Rheumatoid Arthritis Using HR-pQCT
Status:
COMPLETED
Status Verified Date:
2020-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the effects of denosumab on erosion healing and change in physical function in RA patients
Detailed Description:
This is a randomized double-blind placebo-controlled study which aimed to evaluate the effects of denosumab on erosion healing and change in physical function in rheumatoid arthritis RA patients in low-disease activity or remission receiving synthetic DMARDs sDMARDs treatment using High-resolution peripheral quantitative CT HR-pQCT
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None